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atrial fibrillation (AF) is the most common human arrhyth-
ia. Based on the incidence trends of the past decades,
rojections for the future forecast a further significant
ncrease in the prevalence of the disease (1). AF causes
onsiderable morbidity and mortality, and its management
s complex. The only available curative treatment is catheter
blation, but this technique has a moderate success rate and
ome potentially severe complications. Importantly, the
isease also poses a large economic burden on health care
ystems (2). For these reasons, preventive strategies are
rgently needed.
See page 2319
Obesity represents another major health care problem
ith increasing prevalence and negative effects on the
opulation’s health (3). Obesity is associated with increased
eft atrial size and impaired left ventricular diastolic function
nd could thus theoretically lead to an increased AF risk (4).
ndeed, several previous investigations identified obesity as
risk factor for the development of AF (5,6). It is note-
orthy that to stress the importance of this association,
nvestigators have emphasized the potentially modifiable
ature of this risk factor. However, and despite this empha-
is, data on the effect of dynamic weight changes on the
ssociated AF risk have so far been scarce.
In this issue of the Journal, Tedrow et al. (7) present
ndings from the Women’s Health Study concerning the
ffect of overweight and obesity on the incidence of AF. The
omen’s Health Study was a randomized trial of aspirin
nd vitamin E use in female health care professionals
ithout previous cardiovascular disease. The authors pro-
ide data on the impact, not only of baseline body mass
ndex (BMI), but more importantly of short-term BMI
hanges on AF risk based on updated measures during a
ong-term follow-up of approximately 13 years in a large
opulation of 34,000 women.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.w
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ity Hospital, Athens, Greece.The study corroborates the role of obesity as a risk factor
or AF, showing a linear association between BMI and AF
isk. Furthermore, the authors provide important novel
ndings. First, they convincingly demonstrate an associa-
ion between short-term BMI changes and short-term
hanges in AF risk. As comprehensively shown, women in
hom obesity developed during follow-up showed a signif-
cant 41% increase in AF risk compared with women who
aintained a BMI 30 kg/m2. Remarkably, this increased
isk even exceeded the risk of women who were obese at
aseline and remained obese. In contrast, the AF risk of
omen who were obese at baseline but lost weight and
eached a BMI 30 kg/m2 during follow-up did not differ
rom the risk of women who were nonobese at baseline and
emained nonobese during follow-up. Although the
trength of the latter analysis is somewhat limited by the
elatively small number of subjects (n  599) who lost
eight during follow-up, these findings are essential be-
ause they imply a potential reversibility of the obesity-
ssociated AF risk increase. Second, the authors calculated
he proportion of the observed AF cases that were attribut-
ble to short-term BMI increases and found that this propor-
ion was significant (18%). These results emphasize the role of
eight control as one of the strategies for AF prevention and
hus as a way to battle the rising AF epidemic.
As the authors correctly point out in the Discussion
ection, the study has both strengths and limitations. The
ain limitation is related to the follow-up method applied
or the detection of AF episodes. At several follow-up time
oints, the study participants were asked to report diagnoses
f AF. Those who reported an AF event were sent a
uestionnaire with additional questions and the respective
edical records were reviewed. Numerous previous publi-
ations have shown that asymptomatic AF episodes are very
requent in AF patients (8,9). To detect at least some of
hem, systematic and scheduled electrocardiographic re-
ordings are needed. Regular Holter recordings or repetitive
ranstelephonic short-time electrocardiographic recordings
re recommended for studies with rhythm control as an
utcome parameter (10). Whether such follow-up methods
re necessary for the detection of incident AF in populations
ithout previously observed AF episodes is conjecture.
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May 25, 2010:2328–9 AF and Obesityevertheless, we must assume that the follow-up applied by
edrow et al. (7) was not rigorous enough for the reliable
etection of asymptomatic AF episodes. A better design
ould have been, for instance, to obtain regular Holter
lectrocardiograms from all participants. However, one
ust acknowledge that intense rhythm follow-up methods
n such huge patient populations would be associated with
ogistical problems and an enormous work load and that this
rawback of the study is, at least to some important degree,
ounterbalanced by its main strengths, namely, the very
arge population and the long follow-up.
Another point that needs to be addressed is the selective
emale study population. Sex-related differences in presen-
ation, treatment, and outcome have been reported in
arious cardiovascular diseases and particularly in AF
11,12). Therefore, as the authors correctly mention, the
eneralizability of the findings to male populations is
imited. However, as discussed in the article, there are recent
ata from a Swedish male population that are consistent
ith the presented results (13).
In conclusion, Tedrow et al. (7) demonstrate that changes
n body weight have a significant influence on the associated
F risk. Considering the predictions for the future devel-
pment of both obesity and AF prevalence, weight control
ill probably become an increasingly important strategy, not
nly for prevention of the well-known adverse health effects
ssociated with obesity, but also for prevention of AF.
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2462 Athens, Greece. E-mail: nikolaosdagres@yahoo.de.
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